News - Alpha Lifetech

Home
News

Balancing Diversity and Enrichment Pressure in Iterative SELEX Workflows

2026-05-29 08:30

Iterative SELEX workflows require balancing initial library diversity with gradual enrichment pressure to avoid premature convergence.
Integrating Peptide Library Screening with Cell Based Functional Assays for Lead Identification

2026-05-27 08:30

Integrating peptide library screening with cell-based functional assays bridges the gap between binding affinity and biological activity, improving lead selection by prioritizing functional relevanc...
CD19 CAR-T Therapy Achieves Triple Remission in Refractory Autoimmune Diseases

2026-05-25 08:30

This article demonstrates that a single infusion of CD19 CAR-T cells can achieve simultaneous, drug-free remission of three refractory autoimmune diseases by resetting the B cell compartment.
CD226/DNAM-1 Mechanism as Drug Target and FDA-Approved Products

2026-05-22 08:30

For the CD226/DNAM-1 target, Alpha Lifetech offers products to meet different research needs of customers. In addition, we have extensive experience in protein expression and antibody expression.
Advantages and Limitations of Polyclonal Antibodies in Research Applications

2026-05-21 08:30

Polyclonal antibodies recognize multiple epitopes on a single antigen, enabling high sensitivity and robust detection even when antigens are partially degraded or denatured.

1 2 3 4 5